Mei Pharma, Inc.盘中异动大幅上涨7.64%报2.25美元

市场透视2025-05-15

北京时间2025年05月15日00时06分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价大幅拉升7.64%。截至发稿，该股报2.25美元/股，成交量6658股，换手率0.10%，振幅2.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.57百万美元，每股收益-0.39美元，毛利0.00美元，市盈率-0.38倍。机构评级方面，目前暂无机构对该股做出“买入、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535007702?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 00:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535007702","market":"us","top_or_hot":-1,"title":"Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月15日00时06分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价大幅拉升7.64%。截至发稿，该股报2.25美元/股，成交量6658股，换手率0.10%，振幅2.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.57百万美元，每股收益-0.39美元，毛利0.00美元，市盈率-0.38倍。机构评级方面，目前暂无机构对该股做出“买入、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 00:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月15日00时06分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价大幅拉升7.64%。截至发稿，该股报2.25美元/股，成交量6658股，换手率0.10%，振幅2.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.57百万美元，每股收益-0.39美元，毛利0.00美元，市盈率-0.38倍。机构评级方面，目前暂无机构对该股做出“买入、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b","article_id":"2535007702","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535007702","pubTimestamp":1747238766,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月15日00时06分，Mei Pharma, Inc.股票出现异动，股价大幅拉升7.64%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Polyrizon Ltd.、Nucana Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为4091.82%、3985.55%、1556.07%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.，振幅分别为339.54%、201.95%、135.53%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技"},"translate_title":"Mei Pharma, Inc. jumped 7.64% to $2.25 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEIP":0.9},"content_text":"北京时间2025年05月15日00时06分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价大幅拉升7.64%。截至发稿，该股报2.25美元/股，成交量6658股，换手率0.10%，振幅2.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.57百万美元，每股收益-0.39美元，毛利0.00美元，市盈率-0.38倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Liminatus Pharma Inc C/Wts 30/04/2030 (To Pur Com)涨幅较大，Polyrizon Ltd.、Nucana Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为4091.82%、3985.55%、1556.07%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Onconetix, Inc.，振幅分别为339.54%、201.95%、135.53%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。 该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。 其临床开发产品组合还包括 Zandelisib，一种磷脂酰肌醇 3-激酶 delta 的口服抑制剂，用于治疗复发性慢性淋巴细胞白血病或滤泡性非霍奇金淋巴瘤患者； ME-344，一种基于异黄酮的线粒体抑制剂，用于治疗 HER2 阴性乳腺癌和 Pracinostat，一种口服组蛋白脱乙酰酶抑制剂。 在地理上，所有的商业活动都通过美国地区运作。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535007702","isCrawlerRequest":true}

Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元

精彩评论

Mei Pharma, Inc.盘中异动大幅上涨7.64%报2.25美元